Tech Company Financing Transactions

Allogene Therapeutics Funding Round

Perceptive Advisors, Deerfield Capital and Fidelity Management & Research Company joined a $120 million funding round for Allogene Therapeutics. The financing round was announced on 9/10/2018.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
This financing will help us accelerate the development of our broad portfolio and invest in world class technical operations to make potentially lifesaving cell therapies more readily accessible to patients.

Company Information

Company Status
Private & Independent
Mailing Address
210 E Grand Ave.
San Francisco, CA 94080
Email Address
Allogene Therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors.
Allogene Therapeutics LinkedIn Company Profile
Social Media
Allogene Therapeutics Company Twitter Account
Company News
Allogene Therapeutics News
Allogene Therapeutics on Facebook
Allogene Therapeutics on YouTube

Management Team

Email & Social
Arie Belldegrun
  Arie Belldegrun LinkedIn Profile  Arie Belldegrun Twitter Account  Arie Belldegrun News  Arie Belldegrun on Facebook
Chief Executive Officer
David Chang
  David Chang LinkedIn Profile  David Chang Twitter Account  David Chang News  David Chang on Facebook
Chief Financial Officer
Eric Schmidt
  Eric Schmidt LinkedIn Profile  Eric Schmidt Twitter Account  Eric Schmidt News  Eric Schmidt on Facebook
Chief Scientific Officer
Barbra Sasu
  Barbra Sasu LinkedIn Profile  Barbra Sasu Twitter Account  Barbra Sasu News  Barbra Sasu on Facebook
Chief Technical Officer
Alison Moore
  Alison Moore LinkedIn Profile  Alison Moore Twitter Account  Alison Moore News  Alison Moore on Facebook
Vice President
David Tillett
  David Tillett LinkedIn Profile  David Tillett Twitter Account  David Tillett News  David Tillett on Facebook
VP - Bus. Development
Susie Jun
  Susie Jun LinkedIn Profile  Susie Jun Twitter Account  Susie Jun News  Susie Jun on Facebook
VP - General Counsel
Veer Bhavnagri
  Veer Bhavnagri LinkedIn Profile  Veer Bhavnagri Twitter Account  Veer Bhavnagri News  Veer Bhavnagri on Facebook



Browse more venture capital transactions:

Prev: 9/10/2018: Pika Energy venture capital transaction
Next: 9/10/2018: Sonatype venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary